(Q38288518)

1 September 2017

title

Ursodeoxycholic acid and lithocholic acid exert anti-inflammatory actions in the colon (English)

1 reference

1 September 2017

Natalia K Lajczak

2

0 references

Simon Keely

Simon Keely

10

0 references

Murtaza M Tambuwala

Murtaza M Tambuwala

8

0 references

Joan Ní Gabhann

Joan Ní Gabhann

6

0 references

Aldo Roda

Aldo Roda

11

0 references

author name string

Joseph B J Ward

1

1 reference

1 September 2017

Orlaith B Kelly

3

1 reference

1 September 2017

Aoife M O'Dwyer

4

1 reference

1 September 2017

Ashwini K Giddam

5

1 reference

1 September 2017

Placido Franco

7

1 reference

1 September 2017

Caroline A Jefferies

9

1 reference

1 September 2017

Stephen J Keely

12

1 reference

1 September 2017

publication date

30 March 2017

1 reference

American Journal of Physiology - Gastrointestinal and Liver Physiology

1 September 2017

published in

1 reference

1 September 2017

volume

312

1 reference

1 September 2017

issue

6

1 reference

1 September 2017

page(s)

G550-G558

1 reference

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00256.2016

Intestinal barrier in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00256.2016

Alterations in intestinal microflora, faecal bile acids and short chain fatty acids in dextran sulphate sodium-induced experimental acute colitis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00256.2016

Bile acids in the colon, from healthy to cytotoxic molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00256.2016

Immunomodulating and anti-apoptotic action of ursodeoxycholic acid: where are we and where should we go?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00256.2016

Ulcerative colitis: current pharmacotherapy and future directions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00256.2016

Synthesis and evaluation of water-soluble prodrugs of ursodeoxycholic acid (UDCA), an anti-apoptotic bile acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00256.2016

Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00256.2016

High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00256.2016

Bear bile: dilemma of traditional medicinal use and animal protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00256.2016

Toll-like receptors-2, -3 and -4 expression patterns on human colon and their regulation by mucosal-associated bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00256.2016

Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00256.2016

TGR5 potentiates GLP-1 secretion in response to anionic exchange resins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00256.2016

Detoxification of lithocholic acid, a toxic bile acid: relevance to drug hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00256.2016

Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00256.2016

The effect of lithocholic acid on proliferation and apoptosis during the early stages of colon carcinogenesis: differential effect on apoptosis in the presence of a colon carcinogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00256.2016

Activation of Transmembrane Bile Acid Receptor TGR5 Modulates Pancreatic Islet α Cells to Promote Glucose Homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00256.2016

The effect of dietary prebiotics and probiotics on body weight, large intestine indices, and fecal bile acid profile in wild type and IL10-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00256.2016

Tauroursodeoxycholic acid inhibits experimental colitis by preventing early intestinal epithelial cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00256.2016

Contribution of the 7β-hydroxysteroid dehydrogenase from Ruminococcus gnavus N53 to ursodeoxycholic acid formation in the human colon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00256.2016

Bile acids as metabolic regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00256.2016

Bile salts and cholestasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00256.2016

Mucosal barrier, bacteria and inflammatory bowel disease: possibilities for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00256.2016

Disease-specific alterations in the enteric virome in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00256.2016

Intestinal permeability defects: is it time to treat?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00256.2016

Vitamin D regulates the gut microbiome and protects mice from dextran sodium sulfate-induced colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00256.2016

Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00256.2016

Dextran sodium sulphate colitis mouse model: traps and tricks

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00256.2016

Ursodeoxycholic acid in cholestasis: linking action mechanisms to therapeutic applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00256.2016

The effects of a TGR5 agonist and a dipeptidyl peptidase IV inhibitor on dextran sulfate sodium-induced colitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00256.2016

Importance of disrupted intestinal barrier in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00256.2016

Pregnane X receptor agonists enhance intestinal epithelial wound healing and repair of the intestinal barrier following the induction of experimental colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00256.2016

TGR5-mediated bile acid sensing controls glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00256.2016

New therapeutic avenues in ulcerative colitis: thinking out of the box.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00256.2016

Ursodeoxycholic Acid and Its Taurine- or Glycine-Conjugated Species Reduce Colitogenic Dysbiosis and Equally Suppress Experimental Colitis in Mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00256.2016

Changes in bile acid composition and effect on cytolytic activity of fecal water by ursodeoxycholic acid administration: a placebo-controlled cross-over intervention trial in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00256.2016

The Unexpected Uses of Urso- and Tauroursodeoxycholic Acid in the Treatment of Non-liver Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00256.2016

Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00256.2016

Chemically induced mouse models of intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00256.2016

21 January 2018

Identifiers

DOI

10.1152/AJPGI.00256.2016

1 reference

1 September 2017

1 reference